XTL Bio (XTLB) - Uzoq muddatli qarzning kapitalga koeffitsiyenti

XTL Bio - XTLB emitenti grafik logotipi

XTL Biopharmaceuticals (XTLB) saraton va autoimmun patologiyalarga qarshi yo'naltirilgan dori vositalarining diversifikatsiyalashgan portfeli orqali risklarni minimallashtiradi, shu bilan birga uzoq muddatli qarzning kapitalga nisbati 0.00 darajasida barqarorlashgan. Moliyaviy model yirik sog'liqni saqlash gigantlari bo'lgan hamkorlardan olinadigan royalti va litsenziya to'lovlariga asoslangan. Klinik sinovlarning uzluksizligi kompaniyaning strategik omborlaridagi optimallashtirilgan xomashyo zaxiralari orqali ta'minlanadi.

XTL Biopharmaceuticals Ltd (XTLB): Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022dan 30.10.2026gacha

XTL Biopharmaceuticals (XTLB) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va konsensus maqsadli narx:
Kotirovkalar grafigi XTL Biopharmaceuticals Ltd|XTLB - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati XTL Biopharmaceuticals Ltd.|XTLB - Korxona qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati XTL Biopharmaceuticals|XTLB - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati xtlbio.com|XTLB - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati XTL Biopharmaceuticals|XTLB - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati xtlbio.com|XTLB - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati XTL Biopharmaceuticals Ltd.|XTLB - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi XTL Biopharmaceuticals|Tezkor likvidlik ko‘rsatkichi xtlbio.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
XTLB - Kompaniyaning sof foydasi
Kompaniyaning umumiy tahlili:XTL Biopharmaceuticals Ltd - XTLB
XTL Biopharmaceuticals brend mahsuloti

Autoimmun kasalliklar uchun terapiya vositalarini ishlab chiqish ko'p yillik klinik sinovlarga ulkan investitsiyalarni talab qiladi. Ushbu ko'rsatkich bir yildan ortiq muddatli majburiyatlar hajmini XTL Biopharmaceuticals (XTLB) kompaniyasining umumiy kapitaliga nisbatan taqqoslaydi. U emitentning moliyaviy barqarorligi tashqi qarzlarga qanchalik bog'liqligini aniqlaydi. Keskin pasayish davrida kapitalizatsiya kamayishi xavfini kuzatish investorlar uchun juda muhimdir. Uzoq muddatli qarzning kapitalga nisbatini tahlil qilish orqali kompaniyaning resurslar balansini baholash mumkin.

Muhim raqobatchilar

argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|immunome.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Uzoq muddatli majburiyatlarning kapitalga nisbati|SEPN: Uzoq muddatli qarzning o'z kapitaliga nisbati|PVLA (Pieris Corp) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|SVRA (Savara Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|RIGL: Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati AnaptysBio|Uzoq muddatli qarzning o'z kapitaliga nisbati ATXS|Uzoq muddatli qarzning o'z kapitaliga nisbati ENGN (enGene Bio)|RAPT (rapt.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati JBIO (Aerovate Therapeutics)|aclaristx.com - Uzoq muddatli qarzning o'z kapitaliga nisbati|Kyverna Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Tiziana Life Sciences Ltd. TLSA|Cabaletta Bio, Inc (CABA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Ventyx Biosciences, Inc (VTYX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Theratechnologies Inc.|avalotx.com - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ELDN|AGEN (Agenus, Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati CLYM (Climb Bio, Inc.)|Uzoq muddatli qarzning kapitalga nisbati zurabio.com ZURA|ATYR - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ADAG (Adagene)|ikenaoncology.com (IMA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Shattuck Labs|EQ (Equillium Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Connect Pharma|Uzoq muddatli qarzning kapitalga nisbati IMUX|Uzoq muddatli qarzning o'z kapitaliga nisbati atarabio.com ATRA|Uzoq muddatli qarzning kapitalga nisbati IFRX (InflaRx)|X4 Pharmaceuticals Inc. (XFOR) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ACET: Uzoq muddatli qarzning o'z kapitaliga nisbati|CELU - Uzoq muddatli qarzning kapitalga nisbati|INMB (INmune Bio, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|BRNS: Uzoq muddatli kreditlarning kapitalga nisbati|KZR (Kezar Life Sciences, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|SAB Biotherapeutics Inc. (SABS) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati AKTX|Uzoq muddatli qarzning o'z kapitaliga nisbati enlivex.com ENLV|Uzoq muddatli qarzning kapitalga nisbati QTTB (Q32 Bio)|Uzoq muddatli qarzning kapitalga nisbati geovax.com GOVX|EDSA - Uzoq muddatli qarzning o'z kapitaliga nisbati|IBIO: Uzoq muddatli qarzning o'z kapitaliga nisbati|carismatx.com (CARM) - Uzoq muddatli qarzning o'z kapitaliga nisbati|BOLT - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati HCWB|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi APVO (Aptevo)|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM (AIM ImmunoTech)|Uzoq muddatli kreditlarning kapitalga nisbati ADTX|Uzoq muddatli qarzning o'z kapitaliga nisbati GRI Bio Corp GRI|XORTX Corp - Uzoq muddatli qarzning o'z kapitaliga nisbati|Vyome Holdings Inc - Uzoq muddatli qarzning kapitalga nisbati|REVB: Uzoq muddatli qarzning o'z kapitaliga nisbati|Indaptus Therapeutics, Inc. (INDP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati SCNI (Scinai Immunotherapeutics Ltd)|CALI (CalciMedica Inc) - Uzoq muddatli qarzning kapitalga nisbati|AFMD: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ALLK|Uzoq muddatli qarzning kapitalga nisbati hookipapharma.com (HOOK)|Uzoq muddatli qarzning o'z kapitaliga nisbati IGM Biosciences IGMS|Uzoq muddatli qarzning kapitalga koeffitsiyenti ITOS|OCEA - Uzoq muddatli qarzning o'z kapitaliga nisbati|TC BioPharm Ltd (TCBP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|THRD: Uzoq muddatli qarzning kapitalga nisbati